Wound infections, including biofilms play a significant role in delaying wound healing and are considered to be one of the major challenges in wound management. The presence of non-viable tissue, such as slough, is a prominent feature of chronic wounds and is considered as a barrier against successful wound healing. A key component in wound care is to integrate in our care evidence-based dressings that provides continuous cleaning, antimicrobial activity and which are also effective against biofilms. UrgoClean Ag is a dressing composed of cohesive poly-absorbent fibres impregnated with a silver lipido-colloid matrix (Technology Lipido-Coloid- Ag healing matrix [TLC-Ag]) that has shown very good results in clinical trials, including a prospective, multicentre, non-comparative clinical trial, but also large scale observational studies. In this article, we attempt to replicate the results obtained in Europe in patients from different countries in the Asian Continent by means of a case series.
